Hester Biosciences Profits Soar Amid Robust Sales

Hester Biosciences, a leading animal health products manufacturer, reported a two-fold increase in its net profit during the July-September quarter. Profits reached Rs 8.39 crore, driven by increased revenue from animal and poultry healthcare. Strong domestic demand for milk and dairy products also boosted sales.

Hester Biosciences, a prominent name in animal health products, announced a notable financial performance for the July-September quarter, with net profits doubling year-on-year.

According to a company exchange filing, the consolidated profit after tax surged to Rs 8.39 crore, compared to Rs 4.04 crore during the same quarter last year.

Revenue from operations rose by 19%, reaching Rs 83.69 crore, largely driven by a 4% rise in the animal healthcare sector and a substantial 20% increase in the poultry healthcare division. The company attributed part of its success to strong domestic demand in the milk and dairy sector.

(With inputs from agencies.)